~~<i id='35ABFCEFBD'><strike id='35ABFCEFBD'><tt id='35ABFCEFBD'><pre id='35ABFCEFBD'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

fashion

author：leisure time 2025-08-08 05:32:47 - browse：6

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： First Opinion on colorectal cancer screening: letter and response

hotspot

focus

leisure time

knowledge

AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

WSS

New air purifier tech could be key to improving indoor air quality

In age of alternative facts, a scholarly course on calling out crap

Overprescribed: High cost isn't America's only drug problem

The cancer drug shortage isn’t new — and neither are the solutions

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

UnitedHealth, in a surprise, takes aim at Steward’s physician group

entertainment

fashion

hotspot

Medicare proposal to cover medical devices draws a mixed reaction

At least 13 dead in Texas as scorching temps continue

United colonoscopy coverage change 'may cost lives,' doctors say

Medicare proposal to cover medical devices draws a mixed reaction

How to save PrEP access — and even expand it

Oral obesity drug from Viking Therapeutics hits key early target

Medicare details structure of new drug price negotiation program

Cancer drug shortages should be causing more outrage

Hepatitis C has a cure — but many Americans still lack access to it

Mass General Brigham physicians react to latest merger step

hotspot

United colonoscopy coverage change 'may cost lives,' doctors say

Walensky prepares to leave CDC — and Congress — behind

Multiple sclerosis has subtypes with different best treatments: study

Study: Black kids more likely to die after surgery than white kids

U.K. decision on ALS drug has neurologists, advocates up in arms

Bird flu in dairy cattle: New measures to control spread to humans

focus

focus

leisure time

knowledge